Inflammation in subcutaneous adipose tissue: relationship to adipose cell size.

Division of Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Rm S025, Stanford, CA 94305-5103, USA.
Diabetologia (Impact Factor: 6.49). 10/2009; 53(2):369-77. DOI: 10.1007/s00125-009-1496-3
Source: PubMed

ABSTRACT Inflammation is associated with increased body mass and purportedly with increased size of adipose cells. We sought to determine whether increased size of adipose cells is associated with localised inflammation in weight-stable, moderately obese humans.
We recruited 49 healthy, moderately obese individuals for quantification of insulin resistance (modified insulin suppression test) and subcutaneous abdominal adipose tissue biopsy. Cell size distribution was analysed with a multisizer device and inflammatory gene expression with real-time PCR. Correlations between inflammatory gene expression and cell size variables, with adjustment for sex and insulin resistance, were calculated.
Adipose cells were bimodally distributed, with 47% in a 'large' cell population and the remainder in a 'small' cell population. The median diameter of the large adipose cells was not associated with expression of inflammatory genes. Rather, the fraction of small adipose cells was consistently associated with inflammatory gene expression, independently of sex, insulin resistance and BMI. This association was more pronounced in insulin-resistant than insulin-sensitive individuals. Insulin resistance also independently predicted expression of inflammatory genes.
This study demonstrates that among moderately obese, weight-stable individuals an increased proportion of small adipose cells is associated with inflammation in subcutaneous adipose tissue, whereas size of mature adipose cells is not. The observed association between small adipose cells and inflammation may reflect impaired adipogenesis and/or terminal differentiation. However, it is unclear whether this is a cause or consequence of inflammation. This question and whether small vs large adipose cells contribute differently to inflammation in adipose tissue are topics for future research. Trial registration: NCT00285844.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Adipose tissue mass in mammals is expanding by increasing the average cell volume as well as the total number of the adipocytes. Up-regulation of lipid storage in fully differentiated adipocytes resulting in their enlargement is well documented and thought to be a critical mechanism for the expansion of adipose tissue depots during the growth of both lean and obese animals and human beings. A novel molecular mechanism for the regulation of lipid storage and cell size in rat adipocytes has recently been elucidated for the physiological stimuli, palmitate and hydrogen peroxide, the anti-diabetic sulfonylurea drug, glimepiride, and insulin-mimetic phosphoinositolglycans. It encompasses (i) the release of small vesicles, so-called adiposomes, harbouring the glycosylphosphatidylinositol-anchored (c)AMP-degrading phosphodiesterase Gce1 and 5'-nuceotidase CD73 from large donor adipocytes, (ii) the transfer of the adiposomes and their interaction with detergent-insoluble glycolipid-enriched microdomains of the plasma membrane of small acceptor adipocytes, (iii) the translocation of Gce1 and CD73 from the adiposomes to the intracellular lipid droplets of the acceptor adipocytes and (iv) the degradation of (c)AMP at the lipid droplet surface zone by Gce1 and CD73 in the acceptor adipocytes. In concert, this sequence of events leads to up-regulation of esterification of fatty acids into triacylglycerol and down-regulation of their release from triacylglycerol. This apparent mechanism for shifting the triacylglycerol burden from large to small adipocytes may provide novel strategies for the therapy of metabolic diseases, such as type 2 diabetes and obesity.
    Archives of Physiology and Biochemistry 09/2010; 117(1):23-43.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The relation between cancer and metabolic disorders was proposed several decades ago but the complete puzzle of the mechanisms involved in cancer development and progression remain obscure. In the last years many groups have been studying systemic adipose markers in cancer patients. However, few consistent results were obtained. On the other hand, several studies revealed many aspects of adipose tissue physiology in obesity. Nowadays it is recognized that excessive lipid uptake in adipocytes leads to hypertrophy and consequently to metabolic dysregulation, hypoxia, inflammation, impaired adipocytokine expression and angiogenesis, insulin resistance and macrophage recruitment. In obese patients, tumors commonly co-localize with excessive adipose tissue accumulation and most of the features of hypertrophic adipose tissue are observed in cancer patients, namely breast and colon. This review aims to summarize pathological adipose tissue alterations that may contribute to cancer etiology and development. Copyright © 2013 John Wiley & Sons, Ltd.
    Diabetes/Metabolism Research and Reviews 02/2013; · 2.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective We tested the hypothesis that women with adipocyte hypertrophy in either omental (OM) or subcutaneous (SC) adipose tissue are characterized by alterations in adipocyte lipolysis and adipose tissue expression of genes coding for proteins involved in adipocyte metabolism or inflammation, independent of overall adiposity and fat distribution. Methods OM and SC fat samples were obtained surgically in 44 women (age: 47.1 ± 5.0 years, BMI: 27.7 ± 5.3 kg/m2). In a given depot, women with larger adipocytes than predicted by the regression of adipocyte size vs. total and regional adiposity measurements were considered as having adipocyte hypertrophy, whereas women with smaller adipocytes than predicted were considered as having adipocyte hyperplasia. Results Women with OM adipocyte hypertrophy had significantly lower SC GLUT4 mRNA abundance (p ≤ 0.05), higher SC CEBPB mRNA expression (p ≤ 0.05) as well as higher mRNA expression of OM PLIN (p ≤ 0.05), CD68 (p ≤ 0.10), CD14 (p ≤ 0.10), CD31 (p ≤ 0.05) and vWF (p ≤ 0.05) compared to women with OM adipocyte hyperplasia. OM adipocyte isoproterenol- (10- 10 to 10- 5 M), forskolin- (10- 5 M) and dibutyryl cAMP- (10- 3 M) stimulated lipolysis was higher in women with hypertrophic OM adipocytes (p ≤ 0.05, for all). Women with SC adipocyte hypertrophy had lower SC mRNA expression of GLUT4 (p ≤ 0.10), higher SC mRNA expression of CEBPB (p ≤ 0.05), lower plasma adiponectin concentrations (p ≤ 0.05) and higher SC adipocyte isoproterenol- (10- 9 to 10- 5 M) stimulated lipolysis (p ≤ 0.05) compared to women with SC adipocyte hyperplasia. Conclusion Hypertrophic adipocytes in both fat compartments are characterized by alterations in adipocyte lipolysis and adipose tissue expression of genes coding for proteins involved in adipocyte metabolism or inflammation.
    Metabolism: clinical and experimental 01/2013; · 3.10 Impact Factor


Available from

Similar Publications